Raloxifene, containing Raloxifene Hydrochloride, is a selective estrogen receptor modulator (SERM) classified as an oral medication in this 60 mg/tab, 100-tab pack from Dragon Pharma. Originally developed for osteoporosis and breast cancer prevention, it's used in bodybuilding to prevent gynecomastia and support PCT. As an oral drug, it has minimal hepatotoxicity, no aromatization, and manageable side effects when used responsibly.
Raloxifene binds selectively to estrogen receptors in breast tissue, acting as an antagonist to block estrogen's effects, preventing or reducing gynecomastia. It also stimulates luteinizing hormone (LH) and follicle-stimulating hormone (FSH) release to a lesser extent, aiding natural testosterone production during PCT. Users notice reduced estrogenic side effects and improved hormonal recovery within weeks.
With a half-life of approximately 27 hours, Raloxifene requires daily dosing for consistent effects. It doesn't interact with androgenic pathways, ensuring no anabolic interference. What doesn't happen: no significant testosterone suppression or liver toxicity, but careful monitoring prevents low estrogen symptoms.
Mild side effects like hot flashes may occur, manageable with proper dosing and monitoring.
Raloxifene excels for bodybuilders managing estrogenic side effects or recovering post-cycle, requiring bloodwork and a structured PCT plan to optimize testosterone restoration.
Best for intermediate to advanced bodybuilders addressing gynecomastia or undergoing PCT after steroid cycles; suitable for men. Not recommended for women (except in medical contexts) or those with liver or clotting issues without medical clearance.
| Substance | Raloxifene Hydrochloride |
|---|---|
| Concentration | 60 mg/tab |
| Form | Oral tablets |
| Pack Size | 100 tabs |
| Half-life | ~27 hours |
| Aromatization/Hepatic | Non-aromatizing / Minimal hepatic |
| Primary Use | Gynecomastia prevention, PCT |
| Manufacturer | Dragon Pharma |
| Brand | Evista |
Clomid: Enhances HPTA recovery for comprehensive PCT.
HCG: Stimulates testicular testosterone for PCT synergy.
Arimidex: Inhibits estrogen production for additional control.
Cycle Support: Supports liver and lipid health during PCT.
Raloxifene vs Nolvadex: Raloxifene is more selective for breast tissue, better for gynecomastia; Nolvadex is stronger for testosterone recovery.
Raloxifene vs Arimidex: Raloxifene blocks estrogen receptors; Arimidex inhibits estrogen production, better for on-cycle use.
Raloxifene vs Clomid: Raloxifene excels for gynecomastia; Clomid is more effective for LH/FSH stimulation.
Review labs with a professional where lawful to ensure authenticity and safe dosing.
Raloxifene is used in PCT, starting 1-3 days post-oral steroid or 10-14 days post-long ester. Use 30-60 mg/day for 4-6 weeks, often with Clomid or HCG. Bloodwork ensures HPTA recovery and hormonal balance.
How does Raloxifene work?
It blocks estrogen in breast tissue and supports testosterone recovery; see Mechanism of Action. It prevents gynecomastia—monitor with labs.
Is Raloxifene safe?
It's safe with proper dosing and monitoring, but avoid in clotting disorders; see Side Effects. Consult professionals for safety.
What is Raloxifene?
Raloxifene is an oral SERM for gynecomastia prevention and PCT; see What is Raloxifene. It manages estrogen—consult professionals for safe use.
What is Raloxifene used for?
It's used for gynecomastia prevention and PCT support; see Key Benefits. It suits bodybuilders—use with professional oversight.
When to take Raloxifene?
Take 30-60 mg daily during PCT or for gynecomastia; see How to Use. Use with labs—consult for tailored plans.